U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07703124) titled 'Female-Specific Modifiers for Healthy Early Action in Cardiovascular Risk Trajectories' on July 09.
Brief Summary: Cardiovascular disease is the leading cause of death in women, yet risk is systematically underestimated and preventive interventions are often initiated too late. Women are disproportionately affected by obesity, diabetes, and smoking, but they also derive greater cardioprotective benefit from physical activity, reaching near-maximal protection at approximately half the exercise dose required in men. FEM-HEART targets a critical pre-clinical window by testing whether a personalized app-based intervention and a supervis...